TY  - JOUR 
AU  - Willame, C.
AU  - Dodd, C.
AU  - Durán, C.E.
AU  - Elbers, R.J.H.J.
AU  - Gini, R.
AU  - Bartolini, C.
AU  - Paoletti, O.
AU  - Wang, L.
AU  - Ehrenstein, V.
AU  - Kahlert, J.
AU  - Haug, U.
AU  - Schink, T.
AU  - Diez Domingo, Javier
AU  - Mira-Iglesias, A.
AU  - Carreras, J.J.
AU  - Vergara-Hernández, C.
AU  - Giaquinto, C.
AU  - Barbieri, E.
AU  - Stona, L.
AU  - Huerta, C.
AU  - Martín-Pérez, M.
AU  - García-Poza, P.
AU  - de Burgos, A.
AU  - Martínez-González, M.
AU  - Bryant, V.
AU  - Villalobos, F.
AU  - Pallejà-Millán, M.
AU  - Aragón, M.
AU  - Souverein, P.
AU  - Thurin, N.H.
AU  - Weibel, D.
AU  - Klungel, O.H.
AU  - Sturkenboom, M.C.J.M.
PY  - 2023
SN  - 1873-2518
UR  - http://hdl.handle.net/20.500.11940/21135
AB  - Background: In May 2020, the ACCESS (The vACCine covid-19 monitoring readinESS) project was launched to prepare real-world monitoring of COVID-19 vaccines. Within this project, this study aimed to generate background incidence rates of 41 adverse...
LA  - eng
KW  - Humans
KW  - Cohort Studies
KW  - COVID-19
KW  - COVID-19 Vaccines
KW  - Delivery of Health Care
KW  - European People
KW  - Thrombocytopenia
TI  - Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
DO  - 10.1016/j.vaccine.2022.11.031
T2  - Vaccine
M2  - 251
KW  - AS Santiago
KW  - IDIS
VL  - 41
ER  -